"Generex has also focused on special groups – children and pregnant women. Moscato thinks that his vaccine, which is guided by the four basic blood types, will be effective in 98% of all people on the planet. Additionally, Moscato reports, "The in vivo testing currently in progress is turning out to be much, much better than we anticipated.""

That is encouraging. Tell us about it.